Wei Zeng, Ph.D.

Scientist
Yurogen Biosystems (an ABclonal Company)

Poster(s):

• (T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
  Tuesday, October 22, 2024

  11:30 AM – 12:30 PM MT

• (M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
  Monday, October 21, 2024

  3:30 PM – 4:30 PM MT